Literature DB >> 36262535

Hepatoid adenocarcinoma: A wolf in hepatocellular carcinoma's clothing.

Paul Nguyen1, Samuel Hui1,2, Marcus Robertson1,2.   

Abstract

Hepatoid adenocarcinoma (HAC) is a rare malignancy that may mimic hepatocellular carcinoma (HCC) given its hepatoid histologic appearance and production of alpha fetoprotein. Clinical management and prognosis of HAC varies considerably from HCC. We present two cases of metastatic HAC in a cirrhotic liver diagnosed after biopsy and histopathological evaluation. The cases underscore the importance of recognizing the limitations of diagnostic imaging and pursuing a biopsy where there is diagnostic uncertainty.
© 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  cancers: biology; diagnosis; gastroenterology; hepatocellular carcinoma; hepatoid adenocarcinoma; therapy

Year:  2022        PMID: 36262535      PMCID: PMC9575327          DOI: 10.1002/jgh3.12813

Source DB:  PubMed          Journal:  JGH Open        ISSN: 2397-9070


  7 in total

1.  [Existence of alpha feto protein during gastric-origin secondary cancer of the liver].

Authors:  J Bourreille; P Metayer; F Sauger; F Matray; A Fondimare
Journal:  Presse Med       Date:  1970-06-06       Impact factor: 1.228

Review 2.  Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.

Authors:  Jiann-Sheng Su; Yu-Tso Chen; Ren-Ching Wang; Chun-Ying Wu; Shou-Wu Lee; Teng-Yu Lee
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

3.  Metastases can occur in cirrhotic livers with patent portal veins.

Authors:  Zaid Mahdi; Mark G Ettel; Raul S Gonzalez; John Hart; Lindsay Alpert; Jiayun Fang; Natalia Liu; Suntrea T Hammer; Nicole Panarelli; Jerome Cheng; Joel K Greenson; Paul E Swanson; Maria Westerhoff
Journal:  Diagn Pathol       Date:  2021-02-27       Impact factor: 2.644

4.  Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature.

Authors:  Najla Fakhruddin; Hisham F Bahmad; Tarek Aridi; Yara Yammine; Rami Mahfouz; Fouad Boulos; Ahmad Awada; Fadi Farhat
Journal:  Front Med (Lausanne)       Date:  2017-09-28

5.  Hepatoid adenocarcinoma of the stomach: Thirteen case reports and review of literature.

Authors:  Zheng-Rong Zhang; Jian Wu; Han-Wen Li; Tao Wang
Journal:  World J Clin Cases       Date:  2020-03-26       Impact factor: 1.337

Review 6.  Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuwen Zhou; Yuqing Wang; Jiaming Yuan; Xuelei Ma
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

7.  Incidence and prognostic factors of hepatoid adenocarcinoma: a population-based analysis.

Authors:  Wenting Wang; Guang Li
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.